Cargando…

Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy

Targeting tumors using miniature antibodies is a novel and attractive therapeutic approach, as these biomolecules exhibit low immunogenicity, rapid clearance, and high targeting specificity. However, most of the small-sized antibodies in existence do not exhibit marked anti-tumor effects, which limi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Li, Tian, Caiping, Feng, Song, Fida, Guissi, Zhang, Congying, Ma, Yuxiang, Ai, Guanhua, Achilefu, Samuel, Gu, Yueqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329502/ https://www.ncbi.nlm.nih.gov/pubmed/25699098 http://dx.doi.org/10.7150/thno.10084

Ejemplares similares

Galactose as Broad Ligand for Multiple Tumor Imaging and Therapy
por: Ma, Yuxiang, et al.
Publicado: (2015)

The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy
por: Li, Siwen, et al.
Publicado: (2014)

Multifunctional Gold Nanostar Conjugates for Tumor Imaging and Combined Photothermal and Chemo-therapy
por: Chen, Haiyan, et al.
Publicado: (2013)

Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
por: Niu, Miaomiao, et al.
Publicado: (2013)

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system
por: Li, Siwen, et al.
Publicado: (2018)

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum
por: Li, Siwen, et al.
Publicado: (2020)

Size‐Controlled Boron‐Based Bifunctional Photocathodes for High‐Efficiency Photo‐Assisted Li–O(2) Batteries
por: Li, Ling, et al.
Publicado: (2023)

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies
por: Bergado-Báez, Gretchen, et al.
Publicado: (2022)

Facile synthesis of folate-conjugated magnetic/fluorescent bifunctional microspheres
por: Shen, Mao, et al.
Publicado: (2014)

Novel Linear Peptides with High Affinity to αvβ3 Integrin for Precise Tumor Identification
por: Ma, Yi, et al.
Publicado: (2017)

HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors
por: Yonesaka, Kimio
Publicado: (2021)

Targeting Ribonucleases with Small Molecules and Bifunctional Molecules
por: Borgelt, Lydia, et al.
Publicado: (2023)

Novel agents that downregulate EGFR, HER2, and HER3 in parallel
por: Ferreira, Renan Barroso, et al.
Publicado: (2015)

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
por: Boreddy, Srinivas Reddy, et al.
Publicado: (2023)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

Design, Synthesis, and Bioactivity of Novel Bifunctional Small Molecules for Alzheimer’s disease
por: Liang, Meihao, et al.
Publicado: (2022)

Model-Based Analysis of HER Activation in Cells Co-Expressing EGFR, HER2 and HER3
por: Shankaran, Harish, et al.
Publicado: (2013)

Structure and dynamics of the EGFR/HER2 heterodimer
por: Bai, Xue, et al.
Publicado: (2023)

Gold nanoparticle-based beacon to detect STAT5b mRNA expression in living cells: a case optimized by bioinformatics screen
por: Deng, Dawei, et al.
Publicado: (2015)

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
por: Jänne, Pasi A., et al.
Publicado: (2022)

Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study
por: Peng, Duanyang, et al.
Publicado: (2022)

Fine mapping of a QTL for ear size on porcine chromosome 5 and identification of high mobility group AT-hook 2 (HMGA2) as a positional candidate gene
por: Li, Pinghua, et al.
Publicado: (2012)

Novel harmine derivatives for tumor targeted therapy
por: Li, Siwen, et al.
Publicado: (2015)

Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer
por: Yin, Zi-Jun, et al.
Publicado: (2018)

Correction: Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
Publicado: (2022)

Periodontal Bifunctional Biomaterials: Progress and Perspectives
por: Huang, Qiuxia, et al.
Publicado: (2021)

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
por: Kim, Hwang-Phill, et al.
Publicado: (2009)

Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers
por: Khelwatty, Said A, et al.
Publicado: (2015)

Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma
por: Tateyama, Nami, et al.
Publicado: (2022)

Bifunctional catalysis
por: Dixon, Darren J
Publicado: (2016)

Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI
por: Yonesaka, Kimio, et al.
Publicado: (2019)

A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo
por: Yan, Yan, et al.
Publicado: (2021)

Effect of Bifunctional β Defensin 2-Modified Scaffold on Bone Defect Reconstruction
por: Peng, Yiyu, et al.
Publicado: (2020)

Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
por: Takeda, Masayuki, et al.
Publicado: (2018)

Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
por: Wang, Xiaochun, et al.
Publicado: (2016)

Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
por: Baker, Andrew T., et al.
Publicado: (2014)

EGFR Expression in HER2-Driven Breast Cancer Cells
por: Weinberg, Florian, et al.
Publicado: (2020)

Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2013)

Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation
por: Gibson, William J., et al.
Publicado: (2023)

Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2
por: Wu, Yifen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6dngl399qu03mj3p9qg83f1o1d